Press release
HBIF Beijing 2025 Exhibition Walk Through | Sinofn Group Onsite Highlights
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/understanding-modern-art-4.jpg
On November 13-14, 2025, Sinofn Group participated in the Health Business Innovation Forum (HBIF) Beijing Station, booth B6. The Health Brand Marketing & Innovation Application Forum concluded successfully, showcasing Sinofn's diversified product solutions designed to flexibly meet the needs of product development.
Exhibition Highlights
Sinofn Group focused on scientific nutrition solutions across multiple health segments:
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/640-7.jpg
SEGMENT
SOLUTIONS PRESENTED
Weight Management
From meal replacements to functional supplements, offering multidimensional approaches.
Women's Health
Nutrition solutions for beauty and wellness across the full life cycle.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/640-1-3.jpg
Senior Nutrition
Calcium, glucosamine, and joint/bone health supplements, complemented by cardiovascular and muscle nutrition.
Gut Health
Rich formula library supporting digestive wellness.
Children's Health
Tailored solutions for growth and immunity.
Light Wellness
Flexible, readytouse formulas for modern lifestyle needs.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/640-2-1.jpg
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/screenshot_2025-11-19_040405_922.png
*Picture2: Sinofn's fullchain solution system empowers partners to transform innovation into brand growth engines.
Looking Ahead
Sinofn Group will participate in the HNC Health & Nutrition Expo from June 15-17, 2026, booth 3C65. We look forward to meeting you again in Shanghai next June!
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-11/640-10.png
About HBIF
The Health Business Innovation Forum (HBIF) is a brand marketing conference created by Healthplex Expo, Natural & Nutraceutical Products China (HNC). Since 2022, HBIF has been held eight times across China (Hangzhou, Shanghai, Guangzhou, Beijing, Nanjing) and Europe, attracting 1,000+ professional attendees each session.
HBIF focuses on:
*
Consumer demand insights
*
Brand marketing strategies
*
Product competitiveness & operational efficiency
*
Marketing data analysis
*
New media communication challenges
*
Case studies and best practices
In October 2024, HNC hosted the first European HBIF, including a oneweek "Overseas Delegation Tour" to Italy and Germany. The program featured summits, factory visits, and crossborder collaborations, fostering international partnerships and market opportunities.
Looking forward, HBIF aims to become a flagship forum in the health industry, providing a professional twoway communication platform to promote highquality exchanges and common prosperity.
References
*
About HBIF
https://www.hncexpo.com/en/sz/events/about-hbif/
*
Exhibitor Recommendation
https://mp.weixin.qq.com/s/JsV0qHgGn1MKD_dd05MwjA
Media Contact
Company Name: Sinofn (Tianjin) Pharm-Tech Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hbif-beijing-2025-exhibition-walk-through-sinofn-group-onsite-highlights]
Phone: 022-24928910
Address:No. 60 Weiliu Road, Airport Zone
City: Tianjin 300308
Country: China
Website: https://www.sinofnhealth.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HBIF Beijing 2025 Exhibition Walk Through | Sinofn Group Onsite Highlights here
News-ID: 4280983 • Views: …
More Releases from ABNewswire
Can users install an HVLS fan without interfering with crane?
Image: https://www.abnewswire.com/upload/2025/11/0c8dc27130aa262ae78c827718e38286.jpg
If you're managing a factory or warehouse with an overhead crane system, you've likely asked a critical question: "Can we install an HVLS (High-Volume, Low-Speed) fan without interfering with crane operations?"
The short answer is a resounding yes. Not only is it possible, but it is also one of the most effective ways to improve air circulation, enhance worker comfort, and reduce energy costs in large, high-bay industrial spaces. The…
HVLS Fans for Agriculture | Poultry, Dairy & Livestock Cooling
Image: https://www.abnewswire.com/upload/2025/11/567ce651cfeeacabfc1408e157daf8d1.jpg
For modern farmers, the environment is everything. Heat stress, poor air quality, and moisture aren't just inconveniences-they're direct threats to your animals' health and your bottom line. High-Volume, Low-Speed (HVLS) fans are a game-changing agricultural technology designed to solve these core challenges. From providing essential poultry farm cooling to ensuring effective dairy barn ventilation, our fans create a healthier, more productive operation.
1. Poultry Farm Cooling Fans [https://www.apogeefans.com/hvls-fan-in-cow-barn-farm/] (Targeting Animal…
Desmoid Tumors Market Set for Significant Growth Through 2034, Reveals DelveInsi …
Desmoid Tumors Companies are SpringWorks Therapeutics, Immunome/Ayala Pharmaceuticals, Iterion Therapeutics, Eisai and PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, Ayala Pharmaceuticals, Iterion Therapeutics, Aadi Bioscience, Inc., INSYS Therapeutics Inc, Recursion Pharmaceuticals Inc, and others.
In 2023, the desmoid tumors market across the seven major markets (7MM) was estimated at around USD 89 million and is projected to expand substantially over the coming years. The United States held the largest share, contributing nearly…
Open Angle Glaucoma Clinical Trial Landscape Expands With 20+ Emerging Therapies …
Open Angle Glaucoma companies are Nicox Ophthalmics, Betaliq, Inc., Qlaris Bio, Aerpio Pharmaceuticals, Theratocular Biotek, PolyActiva Pty Ltd., Whitecap Biosciences, JeniVision, EMS and others.
According to DelveInsight's analysis, the global Open-Angle Glaucoma pipeline includes more than 18 active companies developing over 20 therapeutic candidates. The assessment covers clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and key developmental progress.
The "Open Angle Glaucoma Pipeline Insight, 2025" report provides a comprehensive…
